🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsGlucagon receptor agonism and hepatic lipid oxidation — 6 month update Page 3

Glucagon receptor agonism and hepatic lipid oxidation — 6 month update

JennaRN Tue, Jun 4, 2024 at 5:22 AM 12 replies 2,000 viewsPage 3 of 3
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Jun 4, 2024 at 9:37 AM#11
Dr.GutHealth said:
Glucagon receptor agonism and is not that straightforward in my experience

This is exactly right. Dr.GutHealth articulated what I have been trying to explain to my doctor for months. The Glucagon receptor agonism aspect is the most important factor.

40 15Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 37 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 4, 2024 at 9:54 AM#12

Reading this thread on Glucagon receptor agonism hits close to home. Night shift nurse — I started at 279 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 54 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Glucagon receptor — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Jun 4, 2024 at 3:54 PM
12 1TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 9 others
Reply Quote Save Share Report
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Jun 4, 2024 at 10:11 AM#13

Dr.AddMedPHL — that is really helpful context on Glucagon receptor agonism. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

18 18TirzTom, TrialTracker_MD, JennaRN and 15 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Jun 4, 2024 at 10:28 AM#14

To answer JenPlateau's question specifically:

From a clinical standpoint, Glucagon receptor agonism and is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Last edited: Jun 4, 2024 at 12:28 PM
13 17Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 10 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jun 4, 2024 at 10:45 AM#15

Bookmarked 📌 The Glucagon receptor info in this thread is essential. Coming back to this for sure.

10 10DataDave, Dr.GutHealth, amsterdam_pete and 7 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register